Iridium CE Expands Award-Winning AI Simulation Across Five Countries
At the 19th European CME Forum, Iridium will show how patient-informed education and adaptive AI can give clinicians
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
At the 19th European CME Forum, Iridium will show how patient-informed education and adaptive AI can give clinicians worldwide education in their own language, inside their own health systems.
Apex, NC November 02, 2026 –(PR.com)– Most international medical education asks clinicians to do two translations at once: one of language, and one of health system. Iridium Continuing Education is testing a different approach.
At the 19th European CME Forum (19ECF), November 11–13, 2026, in Hoofddorp, the Netherlands, Melissa Wiles, FACEHP, President and Founder of Iridium CE, will lead the 90-minute workshop Without Borders: One Curriculum, Five Countries. They will share early lessons from a pilot that takes one accredited curriculum on adult Lennox-Gastaut syndrome (LGS) to clinicians in the United States, France, Germany, Italy and Spain. Clinicians practice with an AI patient and caregiver who speak their language and live within their health system.
“Clinicians everywhere deserve education that fits the way they practice,” said Wiles. “This pilot asks whether one strong curriculum, shaped by families and adapted by AI, can do that across borders, and we’ll share what we learn, including what was harder than expected.”
Built on what families told us
LGS is a severe, lifelong epilepsy, and adults living with it face the same gaps in every country: a hard move from pediatric to adult care, heavy medication burden, and behavioral and quality-of-life needs that too often go unaddressed.
The pilot builds on a 2025 program Iridium CE developed with the LGS Foundation. Its “tethered education” model put families first: patients and caregivers spoke first, and what they shared shaped the clinician education that followed. The program received the 2025 NAMEC Best Practices Award in Collaboration, presented at the Alliance for Continuing Education in the Health Professions 2026 Annual Conference. The model is described in the Alliance’s Almanac in “Bridging Patient and Caregiver Voices With Provider Education: A Tethered Model for LGS.”
Two new, separately funded programs now take that model further.
United States: families shaping the evidence
The US program, jointly provided by Global Education Group and Iridium CE, continues the partnership with the LGS Foundation. At its center is a caregiver research study under independent Institutional Review Board (IRB) review. It will survey and interview caregivers, and adults with LGS where possible. What families share will shape the needs assessment, the clinician curriculum, family education and the AI simulation itself.
“Caregivers of adults with LGS carry an enormous load, and too often their priorities don’t make it into the exam room,” said Wiles. “Here, their voices shape the education from the start.”
“Tethered education shows what’s possible when patient voices shape accredited education from the start,” said Andrea Funk, CHCP, General Manager, Global Education Group.
Europe: one curriculum, four health systems
A separate European program, delivered with a European accredited provider, brings the same family-informed core to health care professionals in France, Germany, Italy and Spain:
• Live webinars led by leading national epilepsy experts, in their own language
• Conversational AI patient simulation in the clinician’s language, adapted to local treatments, referral pathways and access
• Animated explainer videos in four languages, and documentary shorts that keep families’ own voices
• A country-specific HCP Toolkit linking to validated national-language assessment tools and transition frameworks
The simulation is built once and adapted by AI for each language and health system, so every clinician gets education that reflects their own practice without the program being rebuilt for every market. Iridium’s conversational AI simulation technology is patent pending.
“Clinicians shouldn’t have to translate their education before they can use it,” said Alyssa Rossi, Iridium CE Program Manager. “Our pilot tests whether interactive education can cross borders as easily as a lecture.”
Responsible AI, by design
AI in continuing education is now held to clear standards on both sides of the Atlantic: the EU AI Act’s transparency rules took effect in August 2026, and ACCME issued guidance on responsible AI in accredited education in January 2026. Iridium’s simulation was built with these standards in mind:
• Transparency: learners know they’re talking with an AI patient and caregiver.
• Expert-led: content is written and reviewed by clinical experts and validated by native-speaker clinicians in each country.
• Tested: every country version is beta tested and runs within clinical guardrails.
• Accountable: a written AI policy requires human fact-checking and disclosure to learners.
Closing the knowing–doing gap
Clinicians often know what good care for adults with LGS looks like: tracking more than seizures, reviewing medications, making decisions with families. Yet visits still center on seizure counts, medications keep piling up, and the move to adult care too often falls short. The gap between what clinicians know and what they do is what this program is built to close and to measure.
Iridium uses a mixed-methods approach that goes beyond the posttest:
• What clinicians know: knowledge and competence measured before and after the education.
• What clinicians do: performance in a realistic AI encounter with a patient and caregiver, at the moments where gaps are widest.
• What changes in practice: a three-month follow-up asking how many of their own patients they assessed, reviewed and planned care with differently.
• Why: clinicians’ own reflections and open-ended responses, analyzed to show what helped and what still stands in the way.
Because every country uses the same framework, the results show whether education closes the gap consistently across health systems or where local barriers hold it open.
“A posttest tells you what someone knows,” said Wiles. “We want to see what they do when a family is in front of them, and whether it carries into their practice three months later.”
Recognized for innovation
Iridium’s AI patient simulation has been recognized across therapeutic areas, including the 2026 NAMEC Best Practice in Innovative Educational Methods award, a 2026 Vega Digital Awards Silver, and a 2025 Silver at the 20th Annual w3 Awards. Iridium is also developing an outcomes database to better understand the impact of continuing education and to guide where it is needed most.
Why it matters to supporters of independent medical education
• Patient and caregiver voice built in: families shape the needs assessment, content and simulation, so education reflects what matters most to the people living with the disease.
• More reach per grant: AI adapts one core curriculum and simulation for each country instead of rebuilding from scratch. About half of the European program builds on US work, so funding goes to reaching new clinicians.
• Education that fits local practice: clinicians learn in the language they use with patients, with cases that reflect the treatments and pathways they actually work with, led by respected national experts. Relevance drives participation and practice change.
• Proof of practice change: mixed-methods outcomes connect what clinicians know, what they do in a realistic encounter, and what they change in practice three months later, so supporters can see whether the knowing–doing gap is actually closing, country by country.
• Fully independent: the programs follow ACCME and European accreditation standards, the EFPIA Code and national industry codes. Supporters have no role in content, faculty or delivery.
“Funders are asking the right questions: Is it reaching clinicians? Is it changing practice? Does it reflect what patients and families need? Can we see the results across countries?” said Wiles. “This pilot is designed to answer all four.”
What’s next
Iridium plans to publish the cross-country findings and the US caregiver study in peer-reviewed journals and will present the work at the Alliance 2027 Annual Conference, helping set the standard for global continuing education.
Both programs, Beyond Seizures, Beyond Childhood: Real-World Strategies for Transforming Quality of Life in Adult LGS Patients and Caregivers, are supported by independent educational grants from Jazz Pharmaceuticals.
About Iridium Continuing Education
Iridium Continuing Education, LLC, is an award-winning, ACCME-accredited, women-owned provider based in Apex, North Carolina, serving clinicians in the United States and internationally. Iridium designs education that measures what clinicians do, not just what they know, through patient-centered models, outcomes-based learning and a patent-pending conversational AI patient simulation platform. Recognition includes the 2025 NAMEC Best Practices Award in Collaboration, the 2026 NAMEC Best Practice in Innovative Educational Methods award, a 2026 Vega Digital Awards Silver, a 2025 w3 Awards Silver and the 2025 CACME Outstanding Healthcare Education Activity award. www.iridiumce.com
Contact Information:
Iridium CE
Melissa Wiles
919-357-2609
Contact via Email
www.iridiumce.com
Read the full story here: https://www.pr.com/press-release/983513
Press Release Distributed by PR.com
Media gallery
